Healthways, Inc. (HWAY) Q4 Results Fall Short Due to 'Accounting Treatment'
Tweet Send to a Friend
Healthways, Inc. (NASDAQ: HWAY) reported Q4 EPS of ($0.12), $0.15 worse than the analyst estimate of $0.03. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
